289 related articles for article (PubMed ID: 19367029)
21. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
[TBL] [Abstract][Full Text] [Related]
22. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
[TBL] [Abstract][Full Text] [Related]
23. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
[TBL] [Abstract][Full Text] [Related]
24. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
[TBL] [Abstract][Full Text] [Related]
25. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.
Jafri L; Kashif W; Tai J; Siddiqui I; Azam I; Shahzad H; Ghani F
BMC Nephrol; 2013 May; 14():117. PubMed ID: 23725445
[TBL] [Abstract][Full Text] [Related]
26. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
[TBL] [Abstract][Full Text] [Related]
27. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
Wayne Causey M; Singh N
Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
[TBL] [Abstract][Full Text] [Related]
29. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
[TBL] [Abstract][Full Text] [Related]
31. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
32. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
O'Donoghue M; Chen A; Baggish AL; Anwaruddin S; Krauser DG; Tung R; Januzzi JL
J Card Fail; 2005 Jun; 11(5 Suppl):S9-14. PubMed ID: 15948094
[TBL] [Abstract][Full Text] [Related]
33. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.
Zuber M; Cuculi F; Attenhofer Jost CH; Kipfer P; Buser P; Seifert B; Erne P
Scand Cardiovasc J; 2009; 43(5):324-9. PubMed ID: 19247872
[TBL] [Abstract][Full Text] [Related]
34. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
[TBL] [Abstract][Full Text] [Related]
35. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
36. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.
Balion C; Santaguida PL; Hill S; Worster A; McQueen M; Oremus M; McKelvie R; Booker L; Fagbemi J; Reichert S; Raina P
Evid Rep Technol Assess (Full Rep); 2006 Sep; (142):1-147. PubMed ID: 17764210
[TBL] [Abstract][Full Text] [Related]
37. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
38. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
[TBL] [Abstract][Full Text] [Related]
39. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
[TBL] [Abstract][Full Text] [Related]
40. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
